Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
4-Chloro-1-(2,3-dihydro-1H-indol-1-yl)butan-1-one → 4-[4-(3-Chlorophenyl)piperazin-1-yl]-1-(2,3-dihydro-1H-indol-1-yl)butan-1-one
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | 4-Chloro-1-(2,3-dihydro-1H-indol-1-yl)butan-1-one | HCID 3598062 | — |
| 반응물 | 1-(3-Chlorophenyl)piperazine dihydrochloride | HCID 11957487 | — |
| 생성물 | 4-[4-(3-Chlorophenyl)piperazin-1-yl]-1-(2,3-dihydro-1H-indol-1-yl)butan-1-one | HCID 11952831 | — |
반응 단계
from 1-(3-chlorophenyl)piperazine, dihydrochloride and 4-chloro-1-(2,3-dihydro-1H-indol-1-yl)butan-1-one. Mp 102–107° C. 1H NMR (DMSO-d6): 1.75–1.85 (m, 2H); 2.35 (t, 2H); 2.45–2.55 (m, 6H); 3.10–3.20 (m, 6H); 4.10 (t, 2H); 6.75 (d, 1H); 6.85 (d, 1H); 6.90 (s, 1H); 6.95 (t, 1H); 7.10 (t, 1H); 7.15–7.25 (m, 2H); 8.10 (d, 1H). MS m/z: 384 (MH+), 265, 188.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US07223765B2 |
| 출처 데이터셋 | uspto-grants-2007_05 |
| ORD ID | ord-b45953118af84d75b6dc46d9cc2efa40 |
| 출처 메모 | uspto-grants-2007_05 |